News

The clinical development program includes Phase II studies evaluating IDX719, simeprevir (TMC435) and TMC647055 for the treatment of HCV after an initial drug-drug interaction study, expected to commence

A humanised monoclonal antibody Epratuzuma binds to the CD22 glycoprotein on the surface of B cells and is a well-validated target for hematological cancers. Algeta executive vice president

Champion said each 3.6g packet of Invigorate is packed with 250mg of Sustamine, which combines amino acids including L-Alanine and L-Glutamine. During a study at the University of

Aoxing is involved in developing, manufacturing, as well as distributing narcotic, pain-management, and addiction treatment pharmaceuticals. The company said to make the product available in China market and

Genzyme also reported encouraging early US launch indicators for Aubagio (teriflunomide) such as more than 80% MS specialists prescribing the drug, approximately one in five patients were new

Facility was expanded to accommodate new GMP manufacturing suites and onsite packaging line for larger scale production and cost reduction. Elite chairman and CEO Jerry Treppel said, "Shipping

According to the deal, GVK BIO will deliver a clinical candidate while Endo is responsible for the development and commercialization of the resulting product. GVK BIO CEO Manni

The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North Carolina at Chapel Hill, and The University of Texas Southwestern Medical Center jointly own the patent

The collaboration will focus on evaluating MCHC’s closed hydroponic cultivation system, plant factory system, developed to grow plants. Medicago’s technologies will be used to produce Nicotiana Benthamiana plants